Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Shanghai Pharmaceuticals Holding Co's Days Sales Outstanding or its related term are showing as below:
SHPMF'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 77.84 Med: 94.46 Max: 110.81
Current: 110.81
During the past 13 years, Shanghai Pharmaceuticals Holding Co's highest Days Sales Outstanding was 110.81. The lowest was 77.84. And the median was 94.46.
SHPMF's Days Sales Outstanding is ranked worse than 69.67% of 122
companies
in the Medical Distribution industry
Industry Median: 77.93
vs SHPMF: 110.81
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Pharmaceuticals Holding Co Days Sales Outstanding Chart
SHPMF vs MCK, COR, CAH: Days Sales Outstanding Comparison
For the Medical Distribution subindustry, Shanghai Pharmaceuticals Holding Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Pharmaceuticals Holding Co Days Sales Outstanding vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Shanghai Pharmaceuticals Holding Co's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Shanghai Pharmaceuticals Holding Co's Days Sales Outstanding falls into.
Shanghai Pharmaceuticals Holding Co Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Days Sales Outstanding of 117.72 mean?
Shanghai Pharmaceuticals Holding Co (SHPMF) has a Days Sales Outstanding of 117.72 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Shanghai Pharmaceuticals Holding Co and its competitors. This is 25% above median its historical median of 94.46. Over the past decade, Shanghai Pharmaceuticals Holding Co's Days Sales Outstanding has ranged from 77.84 to 110.81. According to the industry distribution chart, Shanghai Pharmaceuticals Holding Co ranks #85 out of 122 companies in the Medical Distribution industry, placing it in the top 69.7%.
Is Shanghai Pharmaceuticals Holding Co's Days Sales Outstanding too high?
Shanghai Pharmaceuticals Holding Co's current Days Sales Outstanding of 117.72 is 25% above median its 10-year median of 94.46. Over the past 10 years, this metric has ranged from a low of 77.84 to a high of 110.81. The Medical Distribution industry median Days Sales Outstanding is 77.93. Shanghai Pharmaceuticals Holding Co's value of 117.72 is 51.1% above this industry median. Based on the distribution chart, Shanghai Pharmaceuticals Holding Co ranks #85 out of 122 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Shanghai Pharmaceuticals Holding Co has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai Pharmaceuticals Holding Co's Days Sales Outstanding compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Shanghai Pharmaceuticals Holding Co ranks #85 out of 122 companies for Days Sales Outstanding. This places Shanghai Pharmaceuticals Holding Co in the lower half of its industry. The industry median Days Sales Outstanding is 77.93. Shanghai Pharmaceuticals Holding Co's value of 117.72 is 51.1% above this benchmark. Historically, Shanghai Pharmaceuticals Holding Co's own Days Sales Outstanding has ranged from 77.84 to 110.81 over the past decade. While the company's 10-year median is 94.46 vs. the industry median of 77.93, Shanghai Pharmaceuticals Holding Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Distribution company?
The median Days Sales Outstanding among Medical Distribution companies is 77.93, based on 122 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Pharmaceuticals Holding Co's current Days Sales Outstanding of 117.72 is 51.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Shanghai Pharmaceuticals Holding Co and its competitors. For the Medical Distribution industry, the median Days Sales Outstanding is 77.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Pharmaceuticals Holding Co's current Days Sales Outstanding is 117.72, which is 25% above median its own 10-year median of 94.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Pharmaceuticals Holding Co stock overvalued right now?
Shanghai Pharmaceuticals Holding Co (SHPMF) has a current Days Sales Outstanding of 117.72. The stock's GF Value™ is $1.78, compared to a current price of $1.46 — trading 18% below its estimated fair value. The current Days Sales Outstanding is 117.72, which is 25% above median its 10-year median of 94.46 and 51.1% above the Medical Distribution industry median of 77.93. Shanghai Pharmaceuticals Holding Co's overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Shanghai Pharmaceuticals Holding Co (SHPMF), the current Days Sales Outstanding is 117.72 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Pharmaceuticals Holding Co (SHPMF) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Pharmaceuticals Holding Co stock appears to be undervalued.
The current stock price of $1.46 is trading 18% below its estimated GF Value™ of $1.78.
Key valuation signals for SHPMF:
Days Sales Outstanding: 117.72 (25% above median its 10-year median of 94.46)
GF Value™: $1.78 vs. price of $1.46 (18% below fair value)
Industry Position: 51.1% above the Medical Distribution median (#85 of 122)
No single metric tells the full story. See the SHPMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Pharmaceuticals Holding Co Ltd is engaged in the pharmaceutical drug development and distribution business. The Group's reportable segments are: Production, Distribution, Retail, and Other. The majority of its revenue comes from the Distribution segment, which is mainly engaged in distribution, warehousing, and other value-added pharmaceutical supply chain solutions and related services for pharmaceutical manufacturers and dispensers. The Retail segment operates a network of retail pharmacy stores, and the Production segment is mainly engaged in research and development, production, and sales of a broad range of pharmaceutical and healthcare products. Geographically, the Group mainly operates in the People's Republic of China (PRC).
73GF Score
Get the complete analysis for SHPMF
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHPMF has been successfully added to your 
